NMR Screening and Hit Validation in Fragment Based Drug Discovery

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|1|43-67

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.1, 2011-01, pp. : 43-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein NMR-Based Screening in Drug Discovery

By  

Current Pharmaceutical Design, Vol. 12, Iss. 31, 2006-11 ,pp. : 3963-3972

Bentham Science Publishers

Access to resources Recommend Favorite

Application of NMR Screening in Drug Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 3, Iss. 1, 2003-01 ,pp. : 81-97

Bentham Science Publishers

Access to resources Recommend Favorite

Practical Aspects of NMR-based Fragment Discovery

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 16, 2007-08 ,pp. : 1592-1599

Bentham Science Publishers

Access to resources Recommend Favorite

Post Processing of Protein-Compound Docking for Fragment-Based Drug Discovery (FBDD): In-Silico Structure-Based Drug Screening and Ligand-Binding Pose Prediction

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 6, 2010-04 ,pp. : 680-694

Bentham Science Publishers

Access to resources Recommend Favorite

High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?

By Jhoti Harren   Rees Stephen   Solari Roberto  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 12, 2013-12 ,pp. : 1449-1453

Informa Healthcare

Access to resources Recommend Favorite